a16z Capital Management, L.L.C.
Follow13F filer, CIK 1540358, MENLO PARK, CA
a16z Capital Management, L.L.C. reported $1,394,890,890 across 11 holdings for the quarter ended 2025-09-30, in a 13F-HR filed 2025-11-14. Its ten largest share positions make up 99.89% of the portfolio.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001540358-25-000007
- Period
- 2025-09-30
- Reported value
- $1.39B
- Holdings
- 11
- Top 10 weight
- 99.89%
- New
- 2
- Sold out
- 1
Part of the filer group a16z Capital Management, L.L.C.
How groups are builtLargest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| FIGnew | +16,246,129 | $843M |
| METAnew | +212,531 | $156M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| OPENexited | -6,200,821 | -$3.31M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q3 2025
Share positions as resolved from 13F-HR 0001540358-25-000007, largest first. % of portfolio is the value over $1,394,890,890, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| FIGFIGMA INC | 16,246,129 | $843M | 60.41% | new | Timeline | ||
| METAMETA PLATFORMS INC | 212,531 | $156M | 11.19% | new | Timeline | ||
| RVMDREVOLUTION MEDICINES INC | 2,748,523 | $128M | 9.2% | 0 | Timeline | ||
| OMDAOMADA HEALTH INC | 4,614,574 | $102M | 7.31% | 0 | Timeline | ||
| XYZBLOCK INC | 1,016,697 | $73.5M | 5.27% | 0 | Timeline | ||
| MAZEMAZE THERAPEUTICS INC | 1,702,225 | $44.1M | 3.16% | 0 | Timeline | ||
| BIOABIOAGE LABS INC | 3,233,170 | $19M | 1.36% | 0 | Timeline | ||
| NAUTNAUTILUS BIOTECHNOLOGY INC | 17,653,917 | $14.9M | 1.07% | 0 | Timeline | ||
| CAMPCAMP4 THERAPEUTICS CORP | 2,125,339 | $6.38M | 0.46% | 0 | Timeline | ||
| ERASERASCA INC | 2,862,500 | $6.24M | 0.45% | 0 | Timeline | ||
| DNAGINKGO BIOWORKS HOLDINGS INC | 108,568 | $1.58M | 0.11% | 0 | Timeline |
Sold out in Q3 2025
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| OPENOPENDOOR TECHNOLOGIES INC | 6,200,821 | $3.31M | shares |
How Q3 2025 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001540358-25-000007 | base | 2025-11-14 | acceptance time not in the bulk data set |